These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Plasma and extracellular fluid volumes in hypertension. Dustan HP; Tarazi RC; Bravo EL; Dart RA Circ Res; 1973 May; 32():Suppl 1:73-83. PubMed ID: 4712515 [No Abstract] [Full Text] [Related]
5. Predictors of hyperkalemia risk following hypertension control with aldosterone blockade. Khosla N; Kalaitzidis R; Bakris GL Am J Nephrol; 2009; 30(5):418-24. PubMed ID: 19738369 [TBL] [Abstract][Full Text] [Related]
6. Diuretic complications. Greenberg A Am J Med Sci; 2000 Jan; 319(1):10-24. PubMed ID: 10653441 [TBL] [Abstract][Full Text] [Related]
7. Clinical use of potassium supplements and potassium sparing diuretics. Morgan TO Drugs; 1973; 6(3):222-9. PubMed ID: 4778987 [No Abstract] [Full Text] [Related]
8. Problems with potassium and magnesium in diuretic-treated patients. Wester PO; Dyckner T Acta Pharmacol Toxicol (Copenh); 1984; 54 Suppl 1():59-65. PubMed ID: 6324542 [TBL] [Abstract][Full Text] [Related]
9. [Effects of potassium on renin and aldosterone]. Kotchen TA Arch Mal Coeur Vaiss; 1984 Apr; 77 Spec No():87-91. PubMed ID: 6428366 [TBL] [Abstract][Full Text] [Related]
10. Magnesium and potassium-sparing diuretics. Ryan MP Magnesium; 1986; 5(5-6):282-92. PubMed ID: 3543514 [TBL] [Abstract][Full Text] [Related]
11. Sodium handling by the kidney in health and disease. A review. First MR S Afr Med J; 1973 May; 47(19):839-43. PubMed ID: 4575117 [No Abstract] [Full Text] [Related]
12. Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes. Kremer D; Beevers DG; Brown JJ; Davies DL; Ferriss JB; Fraser R; Lever AF; Robertson JI Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():213s-8. PubMed ID: 4361398 [No Abstract] [Full Text] [Related]
13. Diuretics as antihypertensive drugs. Guédon J; Chaignon M; Lucsko M Kidney Int Suppl; 1988 Sep; 25():S177-80. PubMed ID: 3054235 [No Abstract] [Full Text] [Related]
15. Proceedings: On the role of diuretic-and spironolactone-induced hyperaldosteronism on electrolyte excretion in man. Erbler H Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R19. PubMed ID: 4276539 [No Abstract] [Full Text] [Related]
17. Renal excretion of electrolytes in patients on long-term diuretic therapy for arterial hypertension and/or congestive heart failure. Dyckner T; Wester PO Acta Med Scand; 1985; 218(5):443-8. PubMed ID: 4091044 [TBL] [Abstract][Full Text] [Related]
18. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside]. Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983 [TBL] [Abstract][Full Text] [Related]
19. Adequacy of twice daily dosing with potassium chloride and spironolactone in thiazide treated hypertensive patients. Toner JM; Brawn LA; Yeo WW; Ramsay LE Br J Clin Pharmacol; 1991 Apr; 31(4):457-61. PubMed ID: 2049255 [TBL] [Abstract][Full Text] [Related]
20. Relation of plasma aldosterone concentration to diuretic treatment in patients with severe heart disease. Knight RK; Miall PA; Hawkins LA; Dacombe J; Edwards CR; Hamer J Br Heart J; 1979 Sep; 42(3):316-25. PubMed ID: 508454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]